FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Discovery of estrogen receptor 'switches' may aid breast cancer treatment

2.

Predicting adult mortality from oral cancer using a machine learning approach.

3.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

4.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

5.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot